Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial

This publication has 16 references indexed in Scilit:

• Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
  JAMA, 2023
• Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis
  Brain, Behavior, and Immunity, 2021
• Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
  The Lancet Global Health, 2021
• Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19
  JAMA Network Open, 2021
• Prospective options of algae-derived nutraceuticals as supplements to combat COVID-19 and human coronavirus diseases
  Nutrition, 2021
• A minimal common outcome measure set for COVID-19 clinical research
  The Lancet Infectious Diseases, 2020
• Spirulina maxima extract prevents activation of the NLRP3 inflammasome by inhibiting ERK signaling
  Scientific Reports, 2020
• Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
  Quality of Life Research, 2011
• The effects of Spirulina on anemia and immune function in senior citizens
  Cellular & Molecular Immunology, 2011
• Activation of the human innate immune system by Spirulina: augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of Spirulina platensis
  International Immunopharmacology, 2002